Bloomberg News

Bayer’s Dekkers Says Goal Is Organic Growth, ‘Bolt-On’ Deals

October 27, 2011

Oct. 27 (Bloomberg) -- Bayer AG is seeking organic growth as well as “bolt-on” acquisitions in health care and its CropScience unit, Chief Executive Officer Marijn Dekkers said in a teleconference with journalists today.

Dekkers said he “doesn’t want to speculate” about whether Bayer will do a deal the size of Abbott Laboratories, the U.S. drugmaker that last week said it plans to divide into two publicly traded companies next year.

To contact the editor responsible for this story: Naomi Kresge at

The Good Business Issue
blog comments powered by Disqus